Scientist analyzing genomic data in a molecular diagnostics lab

Advancing Care Through
Precision Molecular
diagnostics

Comprehensive genomic testing across cancer, rare diseases, infections, transplantations, pharmacogenomics, and reproductive health.

Advanced Clinical Molecular Diagnostics

From genomic profiling to real-time monitoring, our comprehensive platform transforms molecular data into clinical decisions.

Tumor Genomic Profiling

Tumor Genomic Profiling

Learn More
Tumor informed MRD through ctDNA WGS

Tumor informed MRD through ctDNA WGS

Learn More
Targeted ctDNA Ultra-Deep Sequencing

Targeted ctDNA Ultra-Deep Sequencing

Learn More
Infectious Diseases

Infectious Diseases

Learn More
Transplantation

Transplantation

Learn More
Pharmacogenomics (PGx)

Pharmacogenomics (PGx)

Learn More
Rare Genetic Disorders

Rare Genetic Disorders

Learn More
Reproductive & Prenatal Health

Reproductive & Prenatal Health

Learn More
Inherited Cancer Predisposition

Inherited Cancer Predisposition

Learn More
Cancer Screening

Cancer Screening

Learn More
Scientist pipetting a genomic sample in the laboratory

More Than a Laboratory-
Defining Precision Through
Genomics.

3D Genomix Healthcare is a data-driven molecular diagnostics and precision oncology organization focused on advancing cancer care through deep molecular insights.

Built On Three Pillars

From genomic profiling to real-time monitoring, our comprehensive platform transforms molecular data into clinical decisions.

Data- The Foundation

Data- The Foundation

High-quality molecular data forms the foundation for precision diagnostics, enabling earlier detection, personalized treatment planning, and more confident clinical decisions.

Data-Driven Intelligence- The Engine

Data-Driven Intelligence- The Engine

Advanced bioinformatics and machine-learning-based approaches enable rigorous, interpretable analysis of genomic and multi-omic data.

Diagnosis- The outcome

Diagnosis- The outcome

Accurate, timely diagnosis informs therapeutic decisions, supports ongoing monitoring, and enables treatment adaptation for improved outcomes and clinical confidence.

Solving the Core Challenges in Modern Cancer Care.

  • Two patients, same diagnosis, different molecular drivers.
  • Resistance can emerge without warning.
  • Testing is fragmented across labs.
  • Sensitive strategies for early detection or real-time treatment monitoring remain limited.
Microscopic rendering of a cancer cell
Doctor comforting a patient during a consultation

Our Approach towards the challenges

  • Comprehensive genomic profiling.
  • Unified bioinformatics platform.
  • Therapy decisions informed by molecular drivers.
  • Actionable insights for clinical decision-making.
  • Longitudinal monitoring with liquid biopsy.
  • Early resistance detection via MRD.